妊娠期尿液微生物组动态变化及其对IVF/ICSI结局的预测价值
结果显示临床妊娠者尿液中乳杆菌属丰度显著下降、葡萄球菌属丰度显著上升(均P<0.0001),且治疗前微生物组组成可用于预测IVF/IVF-ICSI后临床妊娠,预测模型在27例额外周期女性中验证,敏感度0.42、特异度1.00。
要点
- 临床妊娠后尿液微生物组中乳杆菌属丰度显著下降、葡萄球菌属显著上升(均P<0.0001)。
- 治疗前尿液微生物组组成或可预测IVF/IVF-ICSI后临床妊娠。
- 预测模型验证敏感度0.42、特异度1.00,特异度高但敏感度有限。
核心结论
- 临床妊娠会导致尿液微生物组的丰度和多样性发生显著变化。
- IVF/IVF-ICSI治疗前的尿液微生物组组成有潜力作为临床妊娠的预测指标。
研究设计与样本
- 在激素治疗和胚胎移植开始前约14周采集晨尿,胚胎移植后16周再次采样。
- 通过16S rRNA基因V1-V3区聚合酶链反应测定微生物组成。
- 临床妊娠数据在首个IVF/IVF-ICSI周期后及1年后收集。
- 预测模型在另外27例首个周期未妊娠并接受额外IVF/IVF-ICSI周期或冻胚移植的女性中验证。
主要发现
- IVF/IVF-ICSI治疗后妊娠的女性中,乳杆菌属丰度显著下降(P<0.0001)。
- IVF/IVF-ICSI治疗后妊娠的女性中,葡萄球菌属丰度显著上升(P<0.0001)。
- 基于治疗前微生物组组成可识别IVF/IVF-ICSI后临床妊娠可能性较低的女性。
- 验证模型中预测无临床妊娠的敏感度为0.42,特异度为1.00。
关键数值与推荐
- 乳杆菌属丰度下降及葡萄球菌属丰度上升在妊娠组均P<0.0001。
- 预测模型验证敏感度0.42、特异度1.00。
临床怎么用
- 治疗前尿液微生物组分析或可辅助识别IVF/IVF-ICSI后临床妊娠可能性较低的女性。
- 临床妊娠后尿液微生物组变化提示孕期微生态监测的潜在价值。
- 预测模型特异度高但敏感度低,暂不宜单独用于临床决策。
局限性
- 研究于2008年开展,方法学与当代临床实践可能存在差异。
- 预测模型敏感度较低(0.42),可能漏判部分无妊娠女性。
- 未报告临床妊娠对微生物组变化的具体机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What is the impact of clinical pregnancy on the composition of the urinary microbiota? DESIGN: Eighty-five women receiving IVF, without or with intracytoplasmic sperm injection (ICSI) treatment were enrolled in a prospective observational study performed in 2008. Approximately 14 weeks before the start of hormonal treatment and embryo transfer, a midstream urine sample was obtained, followed by an additional sample 16 weeks after embryo transfer. The microbial composition was determined by polymerase chain reaction of the V1-V3 regions of the 16S rRNA bacterial gene. Clinical pregnancy data were collected after the first IVF/IVF-ICSI cycle and 1 year later. RESULTS: A significant decrease in the abundance of Lactobacillus species as well as a significant increase in that of Staphylococcus species was observed in women who became pregnant after IVF/IVF-ICSI treatment (both P < 0.0001). In addition, based on the composition of the pretreatment microbiome it was possible to identify women with a lower likelihood of achieving clinical pregnancy after IVF/IVF-ICSI treatment. The resulting prediction model was validated in another 27 women who did not become pregnant during the first cycle and received additional IVF/IVF-ICSI cycle(s) or frozen embryo transfer(s). The model predicted the women with no clinical pregnancy after IVF/IVF-ICSI treatment with a sensitivity of 0.42 and a specificity of 1.00. CONCLUSIONS: The data primarily showed that clinical pregnancy results in significant changes in the abundance and diversity of the urinary microbiota. Coincidentally, it was discovered that the urinary microbiome composition before IVF/IVF-ICSI treatment can potentially be used as a predictor of clinical pregnancy.
引用
- Koedooder R, Maghdid DM, Beckers NGM, et al. Dynamics of the urinary microbiome in pregnancy and the coincidental predictive value of the microbiota for IVF/IVF-ICSI outcome. Reprod Biomed Online. 2021. PMID: 34656437. doi:10.1016/j.rbmo.2021.07.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。